Evidence and experience in extracorporeal membrane oxygenation

Chest

Volumn 139, Issue 4, 2011, Pages 965-

  MacLaren, Graeme ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; HUMAN; HYPOXIA; INFLUENZA A (H1N1); ISCHEMIA; LETTER; MEDICAL EXPERT; PATIENT CARE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; RESPIRATORY FAILURE; SKILL;

EID: 79953736596     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2729     Document Type: Letter

References (5)

1. Morris AH, Hirshberg E, Miller RR III, Statler KD, Hite RD. Counterpoint: efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence? Chest. 2010;138(4):778-781.
2. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979;242(20):2193-2196.
3. Peek GJ, Mugford M, Tiruvoipati R, et al; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351- 1363.
4. Vincent JL. We should abandon randomized controlled trials in the intensive care unit. Crit Care Med. 2010;38(10):S534-S538.
5. Popper KR. The Logic of Scientific Discovery. London, England: Routledge Classics; 2002:28.